{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:07:39Z","timestamp":1761512859564},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jacl.2010.07.007","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T10:43:04Z","timestamp":1280832184000},"page":"435-443","source":"Crossref","is-referenced-by-count":10,"title":["Achieving lipid targets in adults with type 2 diabetes: The\u00a0Stop Atherosclerosis in Native Diabetics Study"],"prefix":"10.1016","volume":"4","author":[{"given":"Marie","family":"Russell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome L.","family":"Fleg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihriye","family":"Mete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Weir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlton","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawn","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara V.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wm. James","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2010.07.007_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diacare.2.2.120","article-title":"Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study","volume":"2","author":"Kannel","year":"1979","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2010.07.007_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/oxfordjournals.aje.a114979","article-title":"Mortality among diabetics in a national sample","volume":"128","author":"Kleinman","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacl.2010.07.007_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/oxfordjournals.aje.a114031","article-title":"Mortality from coronary heart disease in the Tecumseh Study: Long-term effect of diabetes mellitus, glucose tolerance and other risk factors","volume":"121","author":"Butler","year":"1985","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacl.2010.07.007_bib4","series-title":"Diabetes Mellitus","first-page":"792","article-title":"Macrovascular complications of diabetes mellitus","author":"Howard","year":"1996"},{"key":"10.1016\/j.jacl.2010.07.007_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/diacare.18.2.258","article-title":"Kelly West Lecture 1994: hyperglycemia and microvascular and macrovascular disease in diabetes","volume":"18","author":"Klein","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2010.07.007_bib6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2337\/dc08-9018","article-title":"American Diabetes Association; American College of Cardiology Foundation. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation","volume":"31","author":"Brunzell","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2010.07.007_bib7","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/jama.299.14.1678","article-title":"Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial","volume":"299","author":"Howard","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2010.07.007_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ahj.2006.05.021","article-title":"Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes\u2014the Stop Atherosclerosis in Native Diabetics Study (SANDS)","volume":"152","author":"Russell","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacl.2010.07.007_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1751-7176.2009.00121.x","article-title":"Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial","volume":"11","author":"Weir","year":"2009","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacl.2010.07.007_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jacl.2009.09.001","article-title":"Prevention of atherosclerosis with low-density lipoprotein cholesterol lowering\u2014lipoprotein changes and interactions: the SANDS study","volume":"3","author":"Howard","year":"2009","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2010.07.007_bib11","series-title":"Crossing the Quality Chasm: A New Health System for the 21st Century","year":"2001"},{"key":"10.1016\/j.jacl.2010.07.007_bib12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2010.07.007_bib13","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/dc05-2415","article-title":"Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)","volume":"29","author":"Knopp","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2010.07.007_bib14","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacl.2010.07.007_bib15","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2010.07.007_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2010.07.007_bib17","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.106.174516","article-title":"AHA\/ACC; National Heart, Lung, and Blood Institute: AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2010.07.007_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2337\/diacare.29.02.06.dc05-1299","article-title":"Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors","volume":"29","author":"Howard","year":"2006","journal-title":"Diabetes Care"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287410002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287410002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T02:52:08Z","timestamp":1544323928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287410002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1933287410002382"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2010.07.007","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}